|
|
Pelvis Urine (Negative)
|
Pelvis Urine
(Positive)
|
p value
|
Agea(years) |
Agea(years) |
69.0 (66.0-71.0) |
69.0
(65.0-74.0) |
0.686 |
BMIa |
BMIa |
25.4
(23.1-27.5) |
25.8 (23.9-29.0) |
0.176 |
Genderb |
Female |
48 (51.1%) |
13
(37.1%) |
0.113 |
|
Male |
46 (48.9%) |
22 (62.9%) |
|
History of ESWLb |
Absent |
72
(76.6%) |
28 (80.0%) |
0.439 |
|
Present |
22 (23.4%) |
7 (20.0%) |
|
Metabolic Syndromeb |
Absent |
66
(70.2%) |
22 (62.9%) |
0.277 |
|
Present |
28 (29.8%) |
13 (37.1%) |
|
Stone Localizationb |
Lower pole |
19 (20.2%)a
|
1 (2.8%) b
|
0.011* |
|
Middle pole |
5 (5.3%) a
|
0
a
|
|
|
Upper pole |
5 (5.3%) a
|
0
a
|
|
|
Pelvis |
33 (35.1%) a
|
13 (37.1%)
a
|
|
|
Proximal ureter |
18 (19.1%) a
|
8
(22.8%) a
|
|
|
Multiple calyxes |
14 (14.8%) a
|
13
(37.1%) b
|
|
Preoperative Bladder Urine Cultureb |
None |
80 (85.1%)a
|
24 (68.6%)
b
|
0.026^ |
|
Escherichia coli |
9 (9.6%) a
|
3 (8.6%)
a
|
|
|
Pseudomonas aeruginosa |
3 (3.2%) a
|
3
(8.6%) a
|
|
|
Staphylococcus aureus |
0 a
|
1 (2.9%)
a
|
|
|
Enterecocus |
1 (1.1%) a
|
3 (8.6%)
b
|
|
|
Proteus mirabilis |
0 a
|
0
a
|
|
|
Klebsiella |
0 a
|
1 (2.9%)
a
|
|
|
Candida albicans |
1 (1.1%) a
|
0
a
|
|
Preoperative Hydronephrosisb |
None |
43 (95.5%) |
2 (4.5%) |
<0.001* |
|
Grade 1 |
45 (76.3%) |
14 (23.7%) |
|
|
Grade 2 |
6 (27.3%) |
16 (72.7%) |
|
|
Grade 3 |
0 |
3 (100%) |
|
Preoperative Pelvis Urine Densitya (HU) |
Preoperative Pelvis Urine Densitya (HU) |
8.0(6.0-11.0) |
-7.0 (-10.0-3.0) |
<0.001# |
Stone Densitya (HU) |
Stone
Densitya (HU) |
1092.0 (800.0-1250.0) |
950.0
(728.0-1150.0) |
0.078 |
Stone Sizea (mm) |
Stone
Sizea (mm) |
90.0 (80.0-110.0) |
110.0 (90.0-190.0) |
<0.001# |
Postoperative Complicationb |
None |
92 (97.8%) |
29 (89.2%) |
0.007 |
|
Fewer |
2 (2.2%) |
5 (14.3%) |
|
|
Perforation |
0 |
0 |
|
|
Sepsis |
0 |
1 (2.9%) |
|
|
Death |
0 |
0 |
|
Preoperative White Blood Cell
Counta(103/µL) |
Preoperative White Blood Cell
Counta(103/µL) |
8.0 (6.7-9.8) |
7.9 (6.3-9.0) |
0.401 |
Preoperative Neutrophil
Counta(103/µL) |
Preoperative Neutrophil
Counta(103/µL) |
4.3 (3.6-6.1) |
4.2 (3.8-5.8) |
0.824 |
Operation Timea (min) |
Operation
Timea (min) |
60.0 (45.0-70.0) |
70.0 (60.0-75.0) |
0.003# |
Hospitalization Datea(day) |
Hospitalization Datea(day) |
2.0 (2.0-3.0) |
2.0 (2.0-4.0) |
0.379 |
Residual Fragmentb |
Absent |
68
(72.3%) |
22 (62.9%) |
0.409 |
|
Present |
8 (9.0%) |
6 (17.1%) |
|
|
CIRF |
18 (19.1%) |
7 (20.0%) |
|